RxDoctor Payments Data

Renee Burkhart

Nurse Practitioner · Indianapolis, INNPI 1003273178

Payments from drug & device makers

$779in general payments, 2019–2025

Across 42 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$128
  • Novartis$75
  • Novo Nordisk$71
  • Astellas Pharma US Inc$61
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
  • Ultragenyx Pharmaceutical Inc.$49
  • plus $341 from 14 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$779 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$40,533
Medicare patients
187
Services billed
1,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$12,048
ArexvyRsvpref3 Antigen/As01e/Pf23$7,042
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$1,563
Albuterol Sulfate HfaAlbuterol Sulfate25$511
Levothyroxine Sodium41$444
Doxycycline Monohydrate31$367
Atorvastatin Calcium31$335
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$299
Nystatin11$223
Bupropion XlBupropion Hcl11$202
Metformin Hcl ErMetformin Hcl13$186
Cefdinir14$152
Rosuvastatin Calcium24$150
Escitalopram Oxalate15$144
Cephalexin28$133

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$12,04822 claims
GSKArexvy$42$7,04223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →